We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

15 hedge funds and large institutions have $1.4M invested in Redhill Biopharma in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more capital invested

Capital invested by funds: $450K → $1.4M (+$952K)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0% → 0% (+0%)

12% less funds holding

Funds holding: 17 → 15 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
5
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.65M
2
UBS Group
UBS Group
Switzerland
+$36K
3
GS
Gagnon Securities
New York
+$20.5K
4
VF
Virtu Financial
New York
+$15.1K
5
TSS
Two Sigma Securities
New York
+$8.24K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$126K
2
Squarepoint
Squarepoint
New York
-$16K
3
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$3.33K
4
Morgan Stanley
Morgan Stanley
New York
-$446
5
SPIA
Steward Partners Investment Advisory
New York
-$183
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.23M +$1.65M +92,770 New
GS
2
Gagnon Securities
New York
$62.7K +$20.5K +1,150 +32%
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41.5K +$7.24K +406 +15%
UBS Group
4
UBS Group
Switzerland
$26.8K +$36K +2,020 +50,500%
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
$15.9K -$3.33K -187 -13%
VF
6
Virtu Financial
New York
$11K +$15.1K +847 New
MOS
7
MGO One Seven
Ohio
$8.35K – – –
TSS
8
Two Sigma Securities
New York
$6.12K +$8.24K +462 New
Group One Trading
9
Group One Trading
Illinois
$323 – – –
Morgan Stanley
10
Morgan Stanley
New York
$274 -$446 -25 -54%
APC
11
Aspire Private Capital
North Carolina
$215 – – –
Bank of America
12
Bank of America
North Carolina
$96 +$71 +4 +133%
Osaic Holdings
13
Osaic Holdings
Arizona
$55 – – –
Wells Fargo
14
Wells Fargo
California
$12 – – –
JP Morgan Chase
15
JP Morgan Chase
New York
$6 – – –
IA
16
IFP Advisors
Florida
$4 – – –
Jane Street
17
Jane Street
New York
– -$126K -3,472 Closed
Squarepoint
18
Squarepoint
New York
– -$16K -438 Closed
Citigroup
19
Citigroup
New York
– -$166 -5 Closed
SPIA
20
Steward Partners Investment Advisory
New York
– -$183 -5 Closed
AEPWM
21
Atlantic Edge Private Wealth Management
Florida
– -$37 -1 Closed
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
– +$36 +2 +33%

RDHL Hedge Fund Activity: Q1 2024 in Review

15 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2024, worth a combined $1.4M — up 212% from $450K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RDHL and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.65M. The largest seller was Jane Street, exiting entirely with an estimated $126K sold.

  • 15 institutional investors held Redhill Biopharma (RDHL) as of Q1 2024, down from 17 in Q4 2023.
  • Funds reported $1.4M of Redhill Biopharma stock for Q1 2024, up 212% quarter-over-quarter.
  • 3 funds opened new Redhill Biopharma positions in Q1 2024 and 5 closed out, a net change of -2 holders.
  • The largest Redhill Biopharma buyer in Q1 2024 was Sabby Management, an estimated $1.65M added.
  • The largest Redhill Biopharma seller in Q1 2024 was Jane Street, an estimated $126K sold.

Based on aggregated 13F filings for Q1 2024.